^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Lymphomun (FBTA05)

    i
    Other names: FBTA05, Bi20
    Associations

    News

    Trials
    Company:
    NeoPharm, Trion Pharma
    Drug class:
    CD20 inhibitor, CD3 agonist
    Related drugs:
    Associations

    News

    Trials
    2years
    STP-LYM-01: Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation (clinicaltrials.gov)
    P1/2, N=0, Withdrawn, Technical University of Munich | Terminated --> Withdrawn
    Trial withdrawal • Combination therapy
    |
    CD20 (Membrane Spanning 4-Domains A1)
    |
    CD20 positive
    |
    Lymphomun (FBTA05)